Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rischmueller

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Rheumatology|June 25, 1999
Cerebral white matter lesions in primary Sjögren's syndrome: a controlled studyT Coates, J P Slavotinek, M Rischmueller, et al.
The Open Rheumatology Journal|July 18, 2012
Sicca Symptoms and their Association with Chronic Rhinosinusitis in a Community SampleS Lester, M Rischmueller, Lw Tan, et al.
Immunological Reviews|October 31, 1998
Determinant spreading: lessons from animal models and human diseaseJ McCluskey, A D Farris, C L Keech, et al.
Rheumatology International|January 1, 1992
Rheumatic manifestations of infective endocarditisP J Roberts-Thomson, M Rischmueller, R A Kwiatek, et al.
Clinical and Experimental Immunology|March 5, 1998
HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS)M Rischmueller, S Lester, Z Chen, et al.
Internal Medicine Journal|May 20, 2003
Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatmentJ G Walker, M J Ahern, M D Smith, et al.
Internal Medicine Journal|October 15, 2013
Epidemiology of biopsy-proven giant cell arteritis in South AustraliaE Dunstan, S L Lester, M Rischmueller, et al.
European Journal of Immunology|January 1, 1997
Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoireS R Burrows, S L Silins, S M Cross, et al.
Internal Medicine Journal|January 26, 2005
Isolated pulmonary hypertension in sclerodermaS R Cox, J G Walker, M Coleman, et al.
Arthritis and Rheumatism|January 1, 2008
Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose studyP P Tak, R M Thurlings, C Rossier, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Rheumatology|June 25, 1999
Cerebral white matter lesions in primary Sjögren's syndrome: a controlled studyT Coates, J P Slavotinek, M Rischmueller, et al.
The Open Rheumatology Journal|July 18, 2012
Sicca Symptoms and their Association with Chronic Rhinosinusitis in a Community SampleS Lester, M Rischmueller, Lw Tan, et al.
Immunological Reviews|October 31, 1998
Determinant spreading: lessons from animal models and human diseaseJ McCluskey, A D Farris, C L Keech, et al.
Rheumatology International|January 1, 1992
Rheumatic manifestations of infective endocarditisP J Roberts-Thomson, M Rischmueller, R A Kwiatek, et al.
Clinical and Experimental Immunology|March 5, 1998
HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS)M Rischmueller, S Lester, Z Chen, et al.
Internal Medicine Journal|May 20, 2003
Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatmentJ G Walker, M J Ahern, M D Smith, et al.
Internal Medicine Journal|October 15, 2013
Epidemiology of biopsy-proven giant cell arteritis in South AustraliaE Dunstan, S L Lester, M Rischmueller, et al.
European Journal of Immunology|January 1, 1997
Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoireS R Burrows, S L Silins, S M Cross, et al.
Internal Medicine Journal|January 26, 2005
Isolated pulmonary hypertension in sclerodermaS R Cox, J G Walker, M Coleman, et al.
Arthritis and Rheumatism|January 1, 2008
Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose studyP P Tak, R M Thurlings, C Rossier, et al.
Pageof 4